Amy K Schneider

Title: Amy K Schneider: Innovator in Antibody Development

Introduction

Amy K Schneider is a prominent inventor based in Dublin, California. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies. With a total of two patents to her name, Schneider is recognized for her innovative work in immunology.

Latest Patents

Schneider's latest patents focus on antibodies against interleukin-1β. These patents describe fully human monoclonal antibodies directed to the antigen IL-1β. The patents also detail nucleotide sequences encoding and amino acid sequences comprising heavy and light chain immunoglobulin molecules. Specifically, these sequences correspond to contiguous heavy and light chain sequences spanning the framework regions and/or complementarity determining regions (CDRs), particularly from FR1 through FR4 or CDR1 through CDR3. Additionally, the patents cover hybridomas or other cell lines expressing such immunoglobulin molecules and monoclonal antibodies.

Career Highlights

Amy K Schneider is currently employed at Amgen Fremont Inc., where she continues to advance her research in antibody development. Her work has been instrumental in the field, contributing to the understanding and treatment of various diseases.

Collaborations

Some of her notable coworkers include Larry L Green and Raffaella Faggioni, who have collaborated with Schneider on various projects within the company.

Conclusion

Amy K Schneider is a key figure in the development of innovative antibody therapies. Her contributions to the field of immunology are significant and continue to impact medical research and treatment options.